Literature DB >> 28276274

Multi-spectroscopic and molecular modelling approach to investigate the interaction of riboflavin with human serum albumin.

Md Maroof Alam1, Faizan Abul Qais2, Iqbal Ahmad2, Parvez Alam3, Rizwan Hasan Khan3, Imrana Naseem1.   

Abstract

Riboflavin (RF) plays an important role in various metabolic redox reactions in the form of flavin adenine dinucleotide and flavin mononucleotide. Human serum albumin (HSA) is an important protein involved in the transportation of drugs, hormones, fatty acid and other molecules which determine the biodistribution and physiological fate of these molecules. In this study, we have investigated the interaction of riboflavin RF with HSA under simulative physiological conditions using various biophysical, calorimetric and molecular docking techniques. Results demonstrate the formation of riboflavin-HSA complex with binding constant in the order of 104 M-1. Fluorescence spectroscopy confirms intermediate strength having a static mode of quenching with stoichiometry of 1:1. Experimental results suggest that the binding site of riboflavin mainly resides in sub-domain IIA of HSA and that ligand interaction increases the α-helical content of HSA. These parameters were further verified by isothermal titration calorimetry ITC which confirms the thermodynamic parameters obtained by fluorescence spectroscopy. Molecular docking was employed to suggest a binding model. Based on thermodynamic, spectroscopic and computational observations it can be concluded that HSA-riboflavin complex is mainly stabilized by various non-covalent forces with binding energy of -7.2 kcal mol-1.

Entities:  

Keywords:  calorimetry; human serum albumin; molecular docking; riboflavin

Mesh:

Substances:

Year:  2017        PMID: 28276274     DOI: 10.1080/07391102.2017.1298470

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  7 in total

1.  Genotoxicity inhibition by Syzygium cumini (L.) seed fraction and rutin: understanding the underlying mechanism of DNA protection.

Authors:  Mohammad Shavez Khan; Faizan Abul Qais; Iqbal Ahmad; Afzal Hussain; Mohamed F Alajmi
Journal:  Toxicol Res (Camb)       Date:  2018-02-06       Impact factor: 3.524

2.  Physicochemical and Antioxidant Properties of Riboflavin in Dextran70/HSA Systems.

Authors:  Mariana Voicescu; Sorana Ionescu; Cecilia Lete
Journal:  J Fluoresc       Date:  2018-06-26       Impact factor: 2.217

3.  A Comprehensive Investigation of Interactions between Antipsychotic Drug Quetiapine and Human Serum Albumin Using Multi-Spectroscopic, Biochemical, and Molecular Modeling Approaches.

Authors:  Seema Zargar; Tanveer A Wani; Nawaf A Alsaif; Arwa Ishaq A Khayyat
Journal:  Molecules       Date:  2022-04-18       Impact factor: 4.927

4.  Characterization of the interaction between recombinant porcine aminopeptidase N and spike glycoprotein of porcine epidemic diarrhea virus.

Authors:  Yan-Gang Sun; Rui Li; Longguang Jiang; Songlin Qiao; Yubao Zhi; Xin-Xin Chen; Sha Xie; Jiawei Wu; Xuewu Li; Ruiguang Deng; Gaiping Zhang
Journal:  Int J Biol Macromol       Date:  2018-05-24       Impact factor: 6.953

5.  Bioflavonoid (Hesperidin) Restrains Protein Oxidation and Advanced Glycation End Product Formation by Targeting AGEs and Glycolytic Enzymes.

Authors:  Mohd Shahnawaz Khan; Md Tabish Rehman; Mohamed A Ismael; Mohamed F AlAjmi; Ghaida I Alruwaished; Majed S Alokail; Mohammad Rashid Khan
Journal:  Cell Biochem Biophys       Date:  2021-06-10       Impact factor: 2.194

6.  Binding modes of environmental endocrine disruptors to human serum albumin: insights from STD-NMR, ITC, spectroscopic and molecular docking studies.

Authors:  Hongqin Yang; Yanmei Huang; Jiuyang Liu; Peixiao Tang; Qiaomei Sun; Xinnuo Xiong; Bin Tang; Jiawei He; Hui Li
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

7.  The Alleviative Effect of Vitamin B2 on Potassium Bromate-Induced Hepatotoxicity in Male Rats.

Authors:  Iftekhar Hassan; Hossam Ebaid; Ibrahim M Alhazza; Jameel Al-Tamimi
Journal:  Biomed Res Int       Date:  2020-07-30       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.